Australia Fires PBS Experts Committee To Form Smaller Advisory Panels
This article was originally published in PharmAsia News
Australia's government fired more than 20 of the advisors it relied on for determining drug subsidies under the Pharmaceutical Benefits Scheme now undergoing a review of the Life Saving Drugs Program.
You may also be interested in...
Non-profit approach is reassuring for healthcare payers, but vaccines won’t be ready to stop pandemic at its peak.
Executives On The Move: BMS Taps Barclays Exec For Strategy Spot, Epizyme Selects Science Chief And A Board Election At ADC Therapeutics
Bristol-Myers Squibb taps Barclays chair of global life sciences as it EVP, strategy and business development, and cancer therapeutics firm Epizyme Inc. selects a chief scientific officer. At ADC Therapeutics, an oncology drug development company, a new chairman is elected.